We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVTR
8301
DELISTED
Nuvectra Corporation Common Stock
NVTR
$113K ﹤0.01%
33,688
+21,777
+183% +$138K
DHC
8302
Diversified Healthcare Trust
DHC
$2.03B
$112K ﹤0.01%
13,602
-609,486
-98% -$5.08M
FINV
8303
FinVolution Group
FINV
$1.03B
$112K ﹤0.01%
25,851
-476,490
-95% -$2.35M
OXSQ icon
8304
CALL
Oxford Square Capital
OXSQ
$157M
$112K ﹤0.01%
17,500
EGIO
8305
PUT
DELISTED
Edgio, Inc. Common Stock
EGIO
$112K ﹤0.01%
1,040
+255
+32% +$30.5K
LFCR icon
8306
Lifecore Biomedical
LFCR
$179M
$111K ﹤0.01%
+11,856
New +$120K
NXE icon
8307
NexGen Energy
NXE
$6.97B
$111K ﹤0.01%
71,404
-237,345
-77% -$368K
OR icon
8308
CALL
OR Royalties Inc
OR
$6.25B
$111K ﹤0.01%
+10,600
New +$113K
TWI icon
8309
PUT
Titan International
TWI
$445M
$111K ﹤0.01%
22,800
TXMD icon
8310
CALL
TherapeuticsMD
TXMD
$24M
$111K ﹤0.01%
854
-662
-44% -$119K
MTEM
8311
DELISTED
Molecular Templates, Inc.
MTEM
$111K ﹤0.01%
+886
New +$96.3K
GCI
8312
PUT
DELISTED
Gannett Co., Inc
GCI
$111K ﹤0.01%
13,600
+700
+5% +$6.23K
CPRX
8313
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
$110K ﹤0.01%
28,700
+15,400
+116% +$66.5K
NHTC icon
8314
CALL
Natural Health Trends
NHTC
$15.5M
$110K ﹤0.01%
+13,700
New +$143K
GGB icon
8315
CALL
Gerdau
GGB
$9.3B
$109K ﹤0.01%
+35,154
New +$103K
BLNK icon
8316
CALL
Blink Charging
BLNK
$85.9M
$108K ﹤0.01%
40,300
-15,700
-28% -$44.3K
VSTM icon
8317
CALL
Verastem
VSTM
$596M
$108K ﹤0.01%
5,983
-42
-0.7% -$951
VTLE
8318
PUT
DELISTED
Vital Energy
VTLE
$108K ﹤0.01%
1,870
-6,005
-76% -$364K
INAP
8319
CALL
DELISTED
Internap Corporation
INAP
$108K ﹤0.01%
35,800
-4,600
-11% -$16.4K
OCUL icon
8320
CALL
Ocular Therapeutix
OCUL
$2.2B
$107K ﹤0.01%
24,300
-7,000
-22% -$25.9K
UAN icon
8321
CVR Partners
UAN
$1.31B
$106K ﹤0.01%
2,584
+1,208
+88% +$44.6K
AAIC
8322
CALL
DELISTED
Arlington Asset Investment Corp.
AAIC
$106K ﹤0.01%
+15,400
New +$113K
MFIN icon
8323
PUT
Medallion Financial
MFIN
$264M
$105K ﹤0.01%
15,600
+300
+2% +$2.06K
MITK icon
8324
CALL
Mitek Systems
MITK
$877M
$105K ﹤0.01%
10,600
-5,100
-32% -$54.4K
NPTN
8325
PUT
DELISTED
NEOPHOTONICS CORP
NPTN
$105K ﹤0.01%
25,100
-77,300
-75% -$408K

Similar funds

Citadel Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
  • Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.